$ESPR Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Esperion Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Esperion Therapeutics, Inc.. Get notifications about new insider transactions in Esperion Therapeutics, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 28 2021 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Grant | A | 0.00 | 12,376 | 0 | 23,449 | 11.1 K to 23.4 K (+111.77 %) |
May 28 2021 | ESPR | Esperion Therapeut ... | GOTTO ANTONIO M JR MD D PHIL | Director | Grant | A | 0.00 | 12,376 | 0 | 23,449 | 11.1 K to 23.4 K (+111.77 %) |
May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.57 | 80,000 | 1,645,632 | 4,177,964 | 4.1 M to 4.2 M (+1.95 %) |
May 07 2021 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 20.02 | 150,000 | 3,002,850 | 4,097,964 | 3.9 M to 4.1 M (+3.80 %) |
Jan 29 2021 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | A | 32.12 | 175,000 | 5,621,000 | 175,000 | |
Jan 29 2021 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Option Exercise | A | 32.12 | 50,000 | 1,606,000 | 50,000 | |
Jan 29 2021 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Grant | A | 0.00 | 5,000 | 0 | 23,617 | 18.6 K to 23.6 K (+26.86 %) |
Jan 29 2021 | ESPR | Esperion Therapeut ... | Hall Ashley | Chief Development O ... | Option Exercise | A | 32.12 | 31,000 | 995,720 | 31,000 | |
Jan 29 2021 | ESPR | Esperion Therapeut ... | Hall Ashley | Chief Development O ... | Grant | A | 0.00 | 7,000 | 0 | 22,500 | 15.5 K to 22.5 K (+45.16 %) |
Jan 29 2021 | ESPR | Esperion Therapeut ... | Koenig Sheldon L. | Chief Operating Off ... | Option Exercise | A | 32.12 | 150,000 | 4,818,000 | 150,000 | |
Jan 29 2021 | ESPR | Esperion Therapeut ... | Koenig Sheldon L. | Chief Operating Off ... | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
Dec 31 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | M | 2.10 | 10,700 | 22,427 | 262,959 | |
Dec 31 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | M | 2.10 | 10,700 | 22,427 | 122,698 | 112 K to 122.7 K (+9.55 %) |
Nov 04 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 25.31 | 200,000 | 5,062,120 | 3,947,964 | 3.7 M to 3.9 M (+5.34 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Grant | A | 0.00 | 6,106 | 0 | 11,073 | 5 K to 11.1 K (+122.93 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | Fuhrman Alan | Director | Grant | A | 0.00 | 1,221 | 0 | 12,878 | 11.7 K to 12.9 K (+10.47 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | GOTTO ANTONIO M JR MD D PHIL | Director | Grant | A | 0.00 | 6,106 | 0 | 11,073 | 5 K to 11.1 K (+122.93 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | J | 0.00 | 24,565 | 0 | 24,565 | 0 to 24.6 K |
May 29 2020 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 6,106 | 0 | 11,073 | 5 K to 11.1 K (+122.93 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | MCGOVERN MARK E | Director | Grant | A | 0.00 | 6,106 | 0 | 16,073 | 10 K to 16.1 K (+61.26 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | Shepard Jay | Director | Grant | A | 0.00 | 6,106 | 0 | 11,073 | 5 K to 11.1 K (+122.93 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Grant | A | 0.00 | 6,106 | 0 | 19,392 | 13.3 K to 19.4 K (+45.96 %) |
May 29 2020 | ESPR | Esperion Therapeut ... | Woody Tracy M | Director | Grant | A | 0.00 | 6,106 | 0 | 16,040 | 9.9 K to 16 K (+61.47 %) |
May 18 2020 | ESPR | Esperion Therapeut ... | Fuhrman Alan | Director | Grant | A | 0.00 | 11,003 | 0 | 11,657 | 654 to 11.7 K (+1,682.42 %) |
Mar 12 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 43.00 | 2,500 | 107,500 | 111,998 | 109.5 K to 112 K (+2.28 %) |
Mar 02 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 49.00 | 5,000 | 245,000 | 109,498 | 104.5 K to 109.5 K (+4.78 %) |
Jan 27 2020 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 52.12 | 20,000 | 1,042,398 | 3,747,964 | 3.7 M to 3.7 M (+0.54 %) |
Jan 03 2020 | ESPR | Esperion Therapeut ... | Glickman Mark A | Chief Commercial Of ... | Option Exercise | A | 61.34 | 26,625 | 1,633,178 | 26,625 | |
Jan 03 2020 | ESPR | Esperion Therapeut ... | Glickman Mark A | Chief Commercial Of ... | Grant | A | 0.00 | 5,925 | 0 | 25,925 | 20 K to 25.9 K (+29.63 %) |
Jan 03 2020 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Option Exercise | A | 61.34 | 33,900 | 2,079,426 | 33,900 | |
Jan 03 2020 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Grant | A | 0.00 | 7,525 | 0 | 18,673 | 11.1 K to 18.7 K (+67.50 %) |
Jan 03 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | A | 61.34 | 104,175 | 6,390,095 | 104,175 | |
Jan 03 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Grant | A | 0.00 | 23,150 | 0 | 104,498 | 81.3 K to 104.5 K (+28.46 %) |
Jan 03 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Gift | G | 0.00 | 365 | 0 | 81,348 | 81.7 K to 81.3 K (-0.45 %) |
Jan 03 2020 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Gift | G | 0.00 | 1,950 | 0 | 81,173 | 83.1 K to 81.2 K (-2.35 %) |
Nov 08 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.30 | 75,000 | 2,797,560 | 3,727,964 | 3.7 M to 3.7 M (+2.05 %) |
Sep 06 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 35.25 | 2,500 | 88,125 | 78,663 | 76.2 K to 78.7 K (+3.28 %) |
Sep 06 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 33.42 | 148 | 4,946 | 76,163 | 76 K to 76.2 K (+0.19 %) |
Sep 06 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 34.22 | 4,852 | 166,035 | 76,015 | 71.2 K to 76 K (+6.82 %) |
Sep 06 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 33.78 | 80,000 | 2,702,208 | 3,652,964 | 3.6 M to 3.7 M (+2.24 %) |
Aug 02 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 39.56 | 5,000 | 197,800 | 71,163 | 66.2 K to 71.2 K (+7.56 %) |
Jul 25 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 42.65 | 50,000 | 2,132,565 | 3,572,964 | 3.5 M to 3.6 M (+1.42 %) |
Jul 01 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 46.00 | 5,000 | 230,000 | 66,163 | 61.2 K to 66.2 K (+8.17 %) |
May 31 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Grant | A | 0.00 | 4,967 | 0 | 13,286 | 8.3 K to 13.3 K (+59.71 %) |
May 31 2019 | ESPR | Esperion Therapeut ... | Woody Tracy M | Director | Grant | A | 0.00 | 9,934 | 0 | 9,934 | 0 to 9.9 K |
May 31 2019 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Grant | A | 0.00 | 4,967 | 0 | 5,019 | 52 to 5 K (+9,551.92 %) |
May 31 2019 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | J | 0.00 | 24,565 | 0 | 24,565 | 0 to 24.6 K |
May 31 2019 | ESPR | Esperion Therapeut ... | GOTTO ANTONIO M JR MD D PHIL | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | MCGOVERN MARK E | Director | Grant | A | 0.00 | 4,967 | 0 | 9,967 | 5 K to 10 K (+99.34 %) |
May 31 2019 | ESPR | Esperion Therapeut ... | Shepard Jay | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | Woody Tracy M | Director | Grant | A | 0.00 | 9,934 | 0 | 9,934 | 0 to 9.9 K |
May 31 2019 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Grant | A | 0.00 | 4,967 | 0 | 5,019 | 52 to 5 K (+9,551.92 %) |
May 31 2019 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Buy | J | 0.00 | 24,565 | 0 | 24,565 | 0 to 24.6 K |
May 31 2019 | ESPR | Esperion Therapeut ... | GOTTO ANTONIO M JR MD D PHIL | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
May 31 2019 | ESPR | Esperion Therapeut ... | MCGOVERN MARK E | Director | Grant | A | 0.00 | 4,967 | 0 | 9,967 | 5 K to 10 K (+99.34 %) |
May 31 2019 | ESPR | Esperion Therapeut ... | Shepard Jay | Director | Grant | A | 0.00 | 4,967 | 0 | 4,967 | 0 to 5 K |
Apr 05 2019 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Buy | S | 43.62 | 1,500 | 65,430 | 11,092 | 9.6 K to 11.1 K (+15.64 %) |
Apr 05 2019 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Buy | S | 42.71 | 6,500 | 277,615 | 12,592 | 6.1 K to 12.6 K (+106.70 %) |
Apr 01 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 40.00 | 5,000 | 200,000 | 61,163 | 56.2 K to 61.2 K (+8.90 %) |
Mar 21 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 43.48 | 5,000 | 217,400 | 56,163 | 51.2 K to 56.2 K (+9.77 %) |
Mar 21 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 1,356 | 0 | 8,319 | 7 K to 8.3 K (+19.47 %) |
Mar 21 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 17,790 | 0 | 0 | 17.8 K to 0 (-100.00 %) |
Mar 21 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | S | 45.25 | 1,700 | 76,925 | 0 | 1.7 K to 0 (-100.00 %) |
Mar 21 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | S | 44.66 | 13,629 | 608,671 | 1,700 | 15.3 K to 1.7 K (-88.91 %) |
Mar 21 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 17,790 | 0 | 17,790 | 0 to 17.8 K |
Mar 21 2019 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 1,101,080 | 0 | 0 | 1.1 M to 0 (-100.00 %) |
Mar 15 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 49.89 | 50,000 | 2,494,355 | 3,522,964 | 3.5 M to 3.5 M (+1.44 %) |
Mar 14 2019 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | P | 48.73 | 5,000 | 243,650 | 51,163 | 46.2 K to 51.2 K (+10.83 %) |
Mar 14 2019 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.06 | 25,000 | 1,251,500 | 548,726 | 573.7 K to 548.7 K (-4.36 %) |
Jan 07 2019 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 41.29 | 80,000 | 3,303,256 | 3,472,964 | 3.4 M to 3.5 M (+2.36 %) |
Dec 26 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 39.91 | 50,000 | 1,995,725 | 3,392,964 | 3.3 M to 3.4 M (+1.50 %) |
Dec 19 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 47.73 | 60,000 | 2,864,070 | 3,342,964 | 3.3 M to 3.3 M (+1.83 %) |
Nov 30 2018 | ESPR | Esperion Therapeut ... | Bartram Richard | Chief Financial Off ... | Option Exercise | A | 52.38 | 12,000 | 628,560 | 12,000 | |
Nov 30 2018 | ESPR | Esperion Therapeut ... | Lalwani Narendra D. | Chief Operating Off ... | Option Exercise | A | 52.38 | 8,000 | 419,040 | 8,000 | |
Nov 30 2018 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | A | 52.38 | 110,000 | 5,761,800 | 110,000 | |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 60.28 | 5,000 | 301,400 | 1,101,250 | 1.1 M to 1.1 M (-0.45 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 59.48 | 13,610 | 809,523 | 1,106,250 | 1.1 M to 1.1 M (-1.22 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 58.82 | 6,390 | 375,860 | 1,119,860 | 1.1 M to 1.1 M (-0.57 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 57.38 | 2,000 | 114,760 | 1,126,250 | 1.1 M to 1.1 M (-0.18 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 56.19 | 6,500 | 365,235 | 1,128,250 | 1.1 M to 1.1 M (-0.57 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 55.21 | 26,500 | 1,463,065 | 1,134,750 | 1.2 M to 1.1 M (-2.28 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 55.25 | 37,500 | 2,071,875 | 1,161,250 | 1.2 M to 1.2 M (-3.13 %) |
Nov 05 2018 | ESPR | Esperion Therapeut ... | Boxer Capital, LLC | 10% Owner | Sell | S | 54.65 | 2,500 | 136,625 | 1,198,750 | 1.2 M to 1.2 M (-0.21 %) |
Nov 02 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.76 | 227 | 11,523 | 573,726 | 574 K to 573.7 K (-0.04 %) |
Nov 02 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.01 | 2,600 | 130,026 | 573,953 | 576.6 K to 574 K (-0.45 %) |
Oct 18 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.00 | 100 | 5,000 | 576,553 | 576.7 K to 576.6 K (-0.02 %) |
Oct 18 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.02 | 12,673 | 633,903 | 576,653 | 589.3 K to 576.7 K (-2.15 %) |
Oct 18 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.01 | 9,400 | 470,094 | 589,326 | 598.7 K to 589.3 K (-1.57 %) |
Aug 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.65 | 12,100 | 612,865 | 598,726 | 610.8 K to 598.7 K (-1.98 %) |
Aug 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 51.46 | 4,200 | 216,132 | 610,826 | 615 K to 610.8 K (-0.68 %) |
Aug 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 52.91 | 700 | 37,037 | 615,026 | 615.7 K to 615 K (-0.11 %) |
Aug 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 53.68 | 700 | 37,576 | 615,726 | 616.4 K to 615.7 K (-0.11 %) |
Aug 22 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 50.06 | 7,300 | 365,438 | 616,426 | 623.7 K to 616.4 K (-1.17 %) |
Aug 06 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 46.14 | 50,000 | 2,306,970 | 3,282,964 | 3.2 M to 3.3 M (+1.55 %) |
Jul 13 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 41.77 | 50,000 | 2,088,300 | 3,232,964 | 3.2 M to 3.2 M (+1.57 %) |
Jul 03 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 39.48 | 50,000 | 1,973,805 | 3,182,964 | 3.1 M to 3.2 M (+1.60 %) |
Jun 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 3,846 | 0 | 6,963 | 3.1 K to 7 K (+123.39 %) |
Jun 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 21,471 | 0 | 0 | 21.5 K to 0 (-100.00 %) |
Jun 25 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.57 | 60,000 | 2,314,224 | 3,132,964 | 3.1 M to 3.1 M (+1.95 %) |
Jun 11 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 37.79 | 60,000 | 2,267,292 | 3,072,964 | 3 M to 3.1 M (+1.99 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 17.75 | 8,000 | 142,000 | 0 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | M | 14.42 | 5,000 | 72,100 | 0 | |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 8,000 | 0 | 47 | 8 K to 47 (-99.42 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Sell | J | 0.00 | 5,000 | 0 | 8,047 | 13 K to 8 K (-38.32 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 17.75 | 8,000 | 142,000 | 13,047 | 5 K to 13 K (+158.51 %) |
Jun 08 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Buy | M | 14.42 | 5,000 | 72,100 | 5,047 | 47 to 5 K (+10,638.30 %) |
Jun 07 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.47 | 60,000 | 2,308,440 | 3,012,964 | 3 M to 3 M (+2.03 %) |
May 29 2018 | ESPR | Esperion Therapeut ... | Shepard Jay | Director | Option Exercise | A | 37.69 | 18,700 | 704,803 | 18,700 | |
May 25 2018 | ESPR | Esperion Therapeut ... | Braunstein Scott | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 25 2018 | ESPR | Esperion Therapeut ... | GOLDSTEIN DOV A MD | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 25 2018 | ESPR | Esperion Therapeut ... | GOTTO ANTONIO M JR MD D PHIL | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 25 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 25 2018 | ESPR | Esperion Therapeut ... | MCGOVERN MARK E | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 25 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 25 2018 | ESPR | Esperion Therapeut ... | Berkowitz Jeffrey | Director | Option Exercise | A | 38.32 | 4,427 | 169,643 | 4,427 | |
May 25 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Option Exercise | A | 38.32 | 10,100 | 387,032 | 10,100 | |
May 22 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 38.77 | 80,000 | 3,101,760 | 2,952,964 | 2.9 M to 3 M (+2.78 %) |
May 22 2018 | ESPR | Esperion Therapeut ... | BIOTECH TARGET N V | 10% Owner | Buy | P | 42.24 | 50,000 | 2,112,010 | 2,872,964 | 2.8 M to 2.9 M (+1.77 %) |
Mar 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Buy | S | 70.71 | 200 | 14,142 | 623,726 | 623.5 K to 623.7 K (+0.03 %) |
Mar 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Buy | S | 71.36 | 7,100 | 506,656 | 623,926 | 616.8 K to 623.9 K (+1.15 %) |
Mar 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Buy | S | 72.31 | 8,656 | 625,915 | 631,026 | 622.4 K to 631 K (+1.39 %) |
Mar 29 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Sell | S | 73.26 | 9,044 | 662,563 | 639,682 | 648.7 K to 639.7 K (-1.39 %) |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Option Exercise | M | 6.99 | 34,651 | 242,210 | 0 | |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Option Exercise | M | 6.99 | 34,651 | 242,210 | 0 | |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Payment of Exercise | F | 6.99 | 3,608 | 25,220 | 648,726 | 652.3 K to 648.7 K (-0.55 %) |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Payment of Exercise | F | 6.99 | 3,608 | 25,220 | 648,726 | 652.3 K to 648.7 K (-0.55 %) |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Buy | M | 6.99 | 34,651 | 242,210 | 652,334 | 617.7 K to 652.3 K (+5.61 %) |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Buy | M | 6.99 | 34,651 | 242,210 | 652,334 | 617.7 K to 652.3 K (+5.61 %) |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Gift | G | 0.00 | 12,000 | 0 | 617,683 | 629.7 K to 617.7 K (-1.91 %) |
Feb 09 2018 | ESPR | Esperion Therapeut ... | NEWTON ROGER S | Director | Gift | G | 0.00 | 12,000 | 0 | 617,683 | 629.7 K to 617.7 K (-1.91 %) |
Feb 01 2018 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | M | 1.26 | 2,610 | 3,289 | 0 | |
Feb 01 2018 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Option Exercise | M | 1.05 | 1,939 | 2,036 | 0 | |
Feb 01 2018 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | M | 1.26 | 2,610 | 3,289 | 46,163 | 43.6 K to 46.2 K (+5.99 %) |
Feb 01 2018 | ESPR | Esperion Therapeut ... | MAYLEBEN TIMOTHY M | President & CEO | Buy | M | 1.05 | 1,939 | 2,036 | 43,553 | 41.6 K to 43.6 K (+4.66 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Option Exercise | M | 6.99 | 1,193 | 8,339 | 0 | |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Option Exercise | M | 6.99 | 70,042 | 489,594 | 0 | |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 645 | 0 | 3,177 | 2.5 K to 3.2 K (+25.47 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 8,500 | 0 | 0 | 8.5 K to 0 (-100.00 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | S | 71.79 | 11,674 | 838,076 | 15,329 | 27 K to 15.3 K (-43.23 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Payment of Exercise | F | 71.82 | 117 | 8,403 | 27,003 | 27.1 K to 27 K (-0.43 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | M | 6.99 | 1,193 | 8,339 | 27,120 | 25.9 K to 27.1 K (+4.60 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Payment of Exercise | F | 71.82 | 6,814 | 489,381 | 1,101,080 | 1.1 M to 1.1 M (-0.62 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | M | 6.99 | 70,042 | 489,594 | 1,107,894 | 1 M to 1.1 M (+6.75 %) |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Buy | J | 0.00 | 8,500 | 0 | 8,500 | 0 to 8.5 K |
Jan 26 2018 | ESPR | Esperion Therapeut ... | VITULLO NICOLE | Director | Sell | J | 0.00 | 850,000 | 0 | 1,037,852 | 1.9 M to 1 M (-45.02 %) |
Jan 22 2018 | ESPR | Esperion Therapeut ... | JANNEY DANIEL | Director | Option Exercise | M | 6.99 | 71,237 | 497,947 | 0 |